Patent: 5,595,760
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 5,595,760
| Title: | Sustained release of peptides from pharmaceutical compositions |
| Abstract: | The invention features a method of administering a peptide to a patient and delivering the peptide continuously over an extended period of time of at least three days by obtaining a solid pharmaceutical composition including a soluble, gelable salt of the peptide and up to 30 percent, by weight, of a pharmaceutically acceptable, soluble, monomeric carrier, and parenterally administering the solid composition to the patient in one injection, wherein the solid composition automatically forms a gel after interaction with the patient\'s bodily fluids and releases the peptide continuously within the patient over an extended period of at least three days. |
| Inventor(s): | Cherif-Cheikh; Roland (Issy-les-Moulineaux, FR) |
| Assignee: | Delab (Paris, FR) |
| Application Number: | 08/400,610 |
| Patent Claims: | see list of patent claims |
Details for Patent 5,595,760
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | ⤷ Try a Trial | 2039-02-26 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
